Trial Profile
Phase II pilot trial of autologous cell therapy utilising tumour infiltrating lymphocytes [Contego] in patients with breast cancer.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 13 Oct 2011
Price :
$35
*
At a glance
- Drugs Lifileucel (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 13 Oct 2011 New trial record